It is a small molecule acting as dual-action phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor, best described as a selective pan-class I PI3K-inhibitor with balanced activity against mTOR, which is known to play a significant role in the pathogenesis of MF. The gene discussed is MTOR; the disease is mycosis fungoides.